Grants

Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R41/R42 - Clinical Trial Optional)

Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional)

Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Trial Optional)

Pilot Research Opportunities in Crisis Response Services for Suicide Prevention (R34 Clinical Trial Optional)

Research Collaboration Network in Structural Racism Measurement and Modeling (U24 Clinical Trial Optional)

Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional)

Translational Resource Centers to Build Bridges Between Substance Use Epidemiology/Etiology and Prevention Intervention Research (U24 Clinical Trials Not Allowed)

Clinical Trial Readiness to Understand and Develop Solutions to Social, Ethical, Behavioral Implications and Barriers to Health Equity in ADRD (R01 - Clinical Trial Not Allowed)

Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)

CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)

Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional)

HEAL Initiative: JCOIN Phase II Clinical Research Hubs (UM1 Clinical Trial Required)